| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.19 | 2e-06 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-05 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.25 | 4e-05 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.25 | 0.0002 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0004 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0006 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0008 |